1. New Therapies for Hepatitis C: Considerations in Patients with Renal Impairment

   • Sarah Zimner-Rapuch
   • Nicolas Janus
   • Vincent Launay-Vacher

   Leading Article 25 July 2014 Pages: 1307 - 1313

2. Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections

   • J. Alexander Viehman
   • M. Hong Nguyen
   • Yohei Doi

   Therapy in Practice 05 August 2014 Pages: 1315 - 1333

3. Functional Esophageal Disorders: Pharmacological Options

   • Gehanjali Amarasinghe
   • Daniel Sifrim

   Therapy in Practice 08 August 2014 Pages: 1335 - 1344

   

4. Asthma Therapy and Its Effect on Airway Remodelling

   • Rachid Berair
   • Christopher E. Brightling

   Review Article 24 July 2014 Pages: 1345 - 1369

   

5. Tafamidis: A Review of Its Use in Familial Amyloid Polyneuropathy

   • Lesley J. Scott

   Adis Drug Evaluation 15 July 2014 Pages: 1371 - 1378

   

6. Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases

   • Lesley J. Scott

   Adis Drug Evaluation 18 July 2014 Pages: 1379 - 1410

7. Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis

   • Mark Sanford

   Adis Drug Evaluation 26 July 2014 Pages: 1411 - 1433

   

8. Cabozantinib: A Review of Its Use in Patients with Medullary Thyroid Cancer

   • Sheridan M. Hoy

   Adis Drug Evaluation 24 July 2014 Pages: 1435 - 1444

   

9. Nemonoxacin: First Global Approval

   • Raewyn M. Poole

   R&D Insight Report 31 July 2014 Pages: 1445 - 1453

   

10. Erratum to: Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor

    • Henri Bounameaux
    • A. John Camm

    Erratum 20 August 2014 Pages: 1455 - 1455